MPI, CT, and AI Come Together at ASNC2024’s ‘Best of JNC’ Session on CV Risk Prediction

Whether you are attending ASNC2024 in Austin, Texas, or virtually on the Society’s online meeting platform, mark your calendar to attend an innovative new session that will simultaneously showcase several of the best articles published in the Journal of Nuclear Cardiology (JNC) in 2023 while also revealing where the next generation of cardiac imaging is heading.

Research Showcase Meets How-to Guide for Improving Patient Outcomes

One of 60+ sessions in the ASNC2024 program, Next-Gen Cardiac Imaging: PET, CT, and AI in Cardiovascular Risk Prediction – The Best of JNC in 2023 will feature 8 rapid-fire presentations by investigators conducting “cutting-edge research on integrating quantitative myocardial perfusion, CT imaging, and AI to enhance coronary artery disease diagnosis and risk prediction,” says JNC Editor- in-Chief Marcelo F. Di Carli, MD, MASNC. “This session will help attendees refine their use of these technologies to improve patient outcomes.”

From left: JNC Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, and Deputy Editor Panithaya Chareonthaitawee, MD

Dr. Di Carli will co-moderate this session with JNC Deputy Editor Panithaya Chareonthaitawee, MD, on Friday, Sept. 6, at 1:30 PM CDT.

Connect with Nuclear Cardiology Researchers at ASNC2024

Are you seeking opportunities to hear from, and connect with, leading nuclear cardiology researchers? In addition to the “Best of JNC” session, ASNC2024 includes a robust Research and Abstracts Track, which is packed with oral and poster sessions as well as Rapid-Fire Cases sessions. The Amyloidosis Track will showcase research in the Featured Science in Cardiac Amyloidosis session, and the opening plenary session will feature primary results from the HELIOS-B study.

REGISTER FOR ASNC2024